scholarly journals Erratum: Corrigendum: Cyclin B2 and p53 control proper timing of centrosome separation

2014 ◽  
Vol 16 (10) ◽  
pp. 1027-1027 ◽  
Author(s):  
Hyun-Ja Nam ◽  
Jan M. van Deursen
2014 ◽  
Vol 16 (6) ◽  
pp. 535-546 ◽  
Author(s):  
Hyun-Ja Nam ◽  
Jan M. van Deursen

Cells ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 729
Author(s):  
Clara Reglero ◽  
Belén Ortiz del Castillo ◽  
Verónica Rivas ◽  
Federico Mayor ◽  
Petronila Penela

The timing of centrosome separation and the distance moved apart influence the formation of the bipolar spindle, affecting chromosome stability. Epidermal growth factor receptor (EGFR) signaling induces early centrosome separation through downstream G protein-coupled receptor kinase GRK2, which phosphorylates the Hippo pathway component MST2 (Mammalian STE20-like protein kinase 2), in turn allowing NIMA kinase Nek2A activation for centrosomal linker disassembly. However, the mechanisms that counterbalance centrosome disjunction and separation remain poorly understood. We unveil that timely degradation of GRK2 by the E3 ligase Mdm2 limits centrosome separation in the G2. Both knockout expression and catalytic inhibition of Mdm2 result in GRK2 accumulation and enhanced centrosome separation before mitosis onset. Phosphorylation of GRK2 on residue S670 enables a complex pattern of non-K48-linked polyubiquitin chains assembled by Mdm2, which correlate with kinase protein degradation. Remarkably, GRK2-S670A protein fails to phosphorylate MST2 despite overcoming Mdm2-dependent degradation, which results in defective centrosome separation, shorter spindles, and abnormal chromosome congression. Conversely, extra levels of wild-type kinase in the G2 cause increased inter-centrosome distances with longer spindles, also converging in congression issues. Our findings show that the signals enabling activity of the GRK2/MST2/Nek2A axis for separation also switches on Mdm2 degradation of GRK2 to ensure accurate centrosome dynamics and proper mitotic spindle functionality.


Author(s):  
Yun-Jung Kang

Abstract As of 25 July 2021, the Korea Disease Control and Prevention Agency reported 1,422 new COVID-19 cases, 188,848 total cases, and 2.073 total deaths (1.10% fatality rates). Since the first SARS-CoV-2 case was reported, efforts to find a treatment and vaccine against COVID-19 have been widespread. Four vaccines are on the WHO’s emergency use listing and are approved of their usage; BNT162b2, mRNA-1273, AZD1222, and Ad26.COV2.S. Vaccines against SARS-CoV-2 need at least 14 days to achieve effectiveness. Thus, people should abide by prevention and control measures, including wearing masks, washing hands, and social distancing. However, a lot of new cases were reported after vaccinations, as many people did not follow the prevention control measures before the end of the 14 days period. There is no doubt we need to break free from mask mandates. But let us not decide the timing in haste. Even if the mask mandates are eased, they should be changed depending on the number of reported cases, vaccinations, as well as prevention and control measures on how circumstances are changing under the influence of mutant coronavirus.


2018 ◽  
Vol 23 (12) ◽  
pp. 1023-1042 ◽  
Author(s):  
Akihito Inoko ◽  
Tomoki Yano ◽  
Tatsuo Miyamoto ◽  
Shinya Matsuura ◽  
Tohru Kiyono ◽  
...  

Cell Reports ◽  
2016 ◽  
Vol 14 (9) ◽  
pp. 2250-2262 ◽  
Author(s):  
Alessandro De Simone ◽  
François Nédélec ◽  
Pierre Gönczy

2005 ◽  
Vol 96 (5) ◽  
pp. 526-534 ◽  
Author(s):  
Ismail Eralp ◽  
Heleen Lie-Venema ◽  
Marco C. DeRuiter ◽  
Nynke M.S van den Akker ◽  
Ad J.J.C. Bogers ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Linda Smith ◽  
Raed Farzan ◽  
Simak Ali ◽  
Laki Buluwela ◽  
Adrian T. Saurin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document